FilingIndex
← The Wire
SPRBNasdaq

SPRUCE BIOSCIENCES, INC.

Pharmaceutical Preparations · DE · CIK 1683553

SPRUCE BIOSCIENCES, INC. develops and commercializes novel therapies for serious neurological disorders

$143M
Market cap
$55.88
Last close
+1.4%
1D
+2.2%
5D
80K
Volume
Price · last 39 sessions-5.9%
May 4L $47.10 · H $59.37Jun 29
120
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 26, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 20268-KMaterial Agreement · Company UpdateApr 22, 2026424B5424B5Apr 21, 2026424B5424B5Apr 20, 2026DEFA14ADEFA14AApr 9, 2026DEF 14ADEF 14AApr 9, 20268-KAgreement TerminatedMar 20, 2026424B5424B5Mar 9, 20268-KExecutive Change · Material AgreementMar 9, 202610-K10-KMar 9, 20268-KReg FD Disclosure · Company UpdateFeb 5, 20268-KMaterial Agreement · Results of OperationsJan 8, 20268-KExecutive ChangeDec 15, 20258-KExecutive ChangeDec 12, 202510-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KExecutive ChangeOct 17, 20258-KMaterial Agreement · Equity IssuanceOct 8, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KSecurity-Holder Rights · Bylaw AmendmentJul 24, 20258-KDelisting Notice · Company UpdateJun 12, 2025DEFA14ADEFA14AJun 12, 2025DEFA14ADEFA14AJun 6, 2025DEFA14ADEFA14AJun 6, 20258-KMaterial Agreement · Equity IssuanceMay 29, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KDelisting Notice · Exit / Disposal CostsApr 25, 202510-K10-KApr 15, 20258-KResults of Operations · Reg FD DisclosureApr 15, 20258-KResults of OperationsApr 1, 20258-KExecutive ChangeDec 27, 20248-KCompany UpdateDec 10, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KDelisting NoticeOct 28, 202410-Q10-QAug 12, 20248-KResults of OperationsAug 12, 20248-KMaterial Agreement · Company UpdateJun 18, 20248-KCompany UpdateJun 3, 20248-KShareholder VoteMay 24, 202410-Q10-QMay 13, 20248-KResults of OperationsMay 13, 20248-KDelisting NoticeApr 30, 2024DEFA14ADEFA14AApr 5, 2024DEF 14ADEF 14AApr 5, 2024SC 13GTHE SCHEDULE 13GMar 28, 202410-K10-KMar 18, 20248-KResults of Operations · Exit / Disposal CostsMar 13, 2024SC 13GSC 13GFeb 14, 2024SC 13GROSALIND_SPRB_13GJan 30, 20248-KResults of Operations · Reg FD DisclosureJan 8, 202410-Q10-QNov 13, 20238-KResults of OperationsNov 13, 202310-Q10-QAug 14, 20238-KResults of Operations · Company UpdateAug 14, 20238-KShareholder VoteMay 26, 20238-KExecutive ChangeMay 25, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 2023DEFA14ADEFA14AApr 5, 2023DEF 14ADEF 14AApr 5, 202310-K10-KMar 16, 20238-KResults of OperationsMar 16, 2023SC 13GSC 13GFeb 27, 20238-KMaterial Agreement · Equity IssuanceFeb 9, 20238-KMaterial Agreement · Results of OperationsJan 9, 20238-KMaterial Agreement · Agreement TerminatedDec 2, 202210-Q10-QNov 10, 20228-KResults of OperationsNov 10, 202210-Q10-QAug 10, 20228-KResults of OperationsAug 10, 20228-KShareholder VoteMay 27, 202210-Q10-QMay 11, 20228-KResults of OperationsMay 11, 2022

Insider Activity

In the 90 days to Oct 6, 2025: 1 insider bought $9K · 1 sold $10K.

DateInsiderActionSharesPriceValue
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerBuy256$17.91$5K
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerBuy256$17.91$5K
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerSell232$19.33$4K
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerSell232$19.33$4K
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerSell25$17.46$437
Oct 6, 2025Parkman Healthcare Partners LlcTenPercentOwnerSell25$17.46$437

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance